Faculty members
Wings participant WEMA aims to provide early detection of cervical cancer to those in remote communities
Jan 26, 2023
Wing's participant WEMA hopes to improve cervical cancer screening access for people who live in remote areas, both in Canada and abroad.
Mesh AI’s steady growth moving towards success as leader in “intelligent and collaborative” healthcare staff scheduling
Jan 16, 2023
Mesh AI is different from other deep-tech healthcare software companies - both in technology and business model.
Innovative research from three Queen’s researchers promises to make breast cancer surgery safer and less intrusive
Jan 13, 2023
Navi-Knife, an exciting surgical tool created at Queen’s University by Professors, is making a favourable impression in the OR.
January 10, 2023: U.S. Patent No. 11,547,325 "Method and Apparatus for Assessing Sensorimotor Performance"
Jan 10, 2023
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,547,325
December 27, 2022: U.S. Patent No. 11,535,745 "Biobased Additive for Thermoplastic Polyesters"
Dec 27, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,535,745
Wings graduate LenSense aims to improve diagnosis and treatment of glaucoma patients
Dec 15, 2022
A new method developed from Professor Yongjun Lai’s lab at Queen’s University is proving to be more effective in diagnosing glaucoma than current methods.
December 6, 2022: U.S. Patent No. 11,522,510 "High-Output Current Transconductance Amplifier"
Dec 06, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,522,510
Kingston-Syracuse Pathway revives partnership and cross-border collaborations
Nov 30, 2022
Renewed Kingston-Syracuse Pathway collaboration will help facilitate market entry into the U.S. or Canada through soft-landings initiative.
November 29, 2022: U.S. Patent No. 11,512,207 "Anti-smudge and Anti-graffiti Compositions"
Nov 29, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,512,207
November 15, 2022: U.S. Patent No. 11,498,853 "Water with Switchable Ionic Strength"
Nov 15, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,498,853
mDETECT getting ready to commercialize important cancer detection method
Nov 10, 2022
A Queen’s research discovery has the potential to become a game-changer for breast cancer diagnosis and treatment.
November 8, 2022: U.S. Patent No. 11,492,366 "Platinum Compounds for Binding Guanine Quadruplexes"
Nov 08, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,492,366